US Stock MarketDetailed Quotes

ADPT Adaptive Biotechnologies

Watchlist
  • 5.750
  • +0.170+3.05%
Close Nov 6 16:00 ET
  • 5.450
  • -0.300-5.22%
Post 17:25 ET
847.97MMarket Cap-3911P/E (TTM)

Adaptive Biotechnologies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Adaptive Biotechnologies Q3 2024 Estimates Date

Currency：USDNov 7, 2024

Estimate YoY
Revenue
40.23M
+6.09%
EPS
-0.29
+17.23%
Analyst Rating
Buy

Nov 6, 2024

Adaptive Biotechnologies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/Q4 -- / 46.570M --
Nov 7, 2024 2024/Q3 -- / 40.229M --
Aug 1, 2024 2024/Q2 43.190M / 39.388M --
May 7, 2024 2024/Q1 41.873M / 38.780M --
Feb 14, 2024 2023/Q4 45.784M / 48.462M --
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 46.570M--
Nov 7, 20242024/Q3-- / 40.229M--
Aug 1, 20242024/Q243.190M / 39.388M--
May 7, 20242024/Q141.873M / 38.780M--
Feb 14, 20242023/Q445.784M / 48.462M--

Unlock Free Earnings Estimates

Adaptive Biotechnologies Earnings Reports

  • Adaptive Biotechnologies | 10-Q: Q2 2024 Earnings Report

    Aug 2 04:32

  • Adaptive Biotechnologies | 10-Q: Q1 2024 Earnings Report

    May 8 04:39

  • Adaptive Biotechnologies | 10-K: FY2023 Annual Report

    Mar 1 11:32

  • Adaptive Biotechnologies | 10-Q: Q3 2023 Earnings Report

    Nov 10, 2023 05:30

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 6, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data